| Line Item | Y1 $ | Y1 % | Y2 $ | Y2 % | Y3 $ | Y3 % | Y4 $ | Y4 % | Y5 $ | Y5 % |
|---|
Sources: 2026 CMS MPFS Final Rule (NP billing factor ×0.85, GA Locality 03) · 2026 CLFS (lab and rapid-test codes, confirmed against the CMS CY2026 Q3 Clinical Diagnostic Laboratory Fee Schedule Public Use File) · NP-capacity-derived ramp schedule (see Assumptions). Every rate is listed with its sourcing note in the Assumptions tab's Billing Code Sheet. No HPSA bonus applied (deliberate simplification — see Assumptions). RPM device COGS $40/enrolled/mo (Tenovi, unverified vendor cost). POC chemistry + PT/INR (Piccolo, CoaguChek), rapid tests, and in-house lab devices (Afinion 2, Clinitek, Sysmex XW-100) COGS = 25%/50% margin on rate (team-set percentages, replacing the old flat $8.00/cartridge placeholder). Vaccine product codes (90662, 90677) COGS = ASP+6% back-out. MSO overhead includes $132K/yr ongoing compliance/legal/marketing. All figures subject to final billing validation. Consult CPA + CMS billing counsel before investor distribution.
| Mo | Period | Avg Stage | Members | Net PMPM | Total PMPM | Total Anc PMPM | Memb Rev | Anc Net | Denial | Net Rev | Clinic Staff | Clinic Ops | Tech Stack | D&A | MSO | Total Exp | EBITDA | Net |
|---|
| Mo | Members | G0558 | CCM | G0557 | G0556 | RPM | Avg Visit Freq | E&M New | E&M Est | Total PMPM | Total Anc PMPM | Ancillary COGS | Claim Denial | Net PMPM | Memb Rev | Anc Net | Net Rev | Clinic Staff | Clinic Ops | Clinic Tech | EBITDA | Milestone |
|---|
| Mo | Members | Avg Visit Freq | NP Demand (E&M visits/mo) | NP Team | NP Capacity (visits/mo) | Utilization | Staff on Duty | Hire Event |
|---|
actualClinicStaffingAt(clinic, TIMELINE)) — not a separate one-time Day-1 sizing formula. It's shown here for reference (FT/PT capacity math, utilization) alongside the Clinic Stages tab's month-by-month view of the same algorithm actually ramping up from 1 FT NP + 1 LPN.BILLING_CODE_SHEET JavaScript object near the top of this page's script — it is not hand-typed HTML. Changing a rate in that one object is the only thing needed to update the entire model's output. All rates already include the ×0.85 NP (nurse practitioner) billing-factor discount and exclude any HPSA bonus (removed — see below), except CLFS lab codes (83036, 80061, 82043, 86140, 85025), which are paid under the Clinical Laboratory Fee Schedule and are not subject to either adjustment. "Confirmed" = verified 2026 CMS rate this session. "Unconfirmed" = physician-fee-schedule figure carried forward without independent verification this session. "Approximate" = a rough proxy rate, not a precise CMS lookup. "Team-set" = a figure the team chose directly rather than sourcing from a fee schedule.
| Code | Description | Rate | Source | Sourcing Note |
|---|
pmpmScale = PMPM_CEIL / BASE_PMPM multiplier. No such mechanism exists anywhere in this codebase.staffClinic()'s TERMINAL capacity determination from Day 1 — but that conflates "how big this clinic can eventually get" with "how many people it actually employs this month." A 20-member clinic doesn't pay for the 2 FT + 1 PT NP team its terminal panel will eventually justify. This rebuild adds LPN/MA, Care Coordinator, and Front Desk roles, all priced against ACTUAL current-month membership via actualClinicStaffingAt(clinic, mo), not the terminal ceiling.actualClinicStaffingAt(c, TIMELINE). This is what the clinic grows INTO, not what it pays on Day 1 — see the Clinic Stages tab for the month-by-month ramp-up of NP, LPN→MA, Care Coordinator, and Front Desk hires. Updates automatically with the Penetration and Ramp Timeline toggles.| Clinic | FFS Pool | NP Staffing | Support Staff | Clinical+Support/yr | Driver/yr | Physicians/yr | Total/yr | Total/mo |
|---|
| Equipment | Description | Introduce | At Members | CLIA | Hardware Cost | Ongoing Cost | Revenue / COGS Treatment |
|---|---|---|---|---|---|---|---|
| Phase 1 · Day 1 (Mandatory at Launch) | |||||||
| Tenovi 4G Cellular RPM Hub | BP cuff + glucose + weight + pulse ox. No WiFi needed. | Day 1 | 0 | None | $0 upfront | $28–$35/device/mo | Bills 99453 (one-time setup) + 99454 + 99445 + 99457/99458 (85% of management-qualified pts) + 99470 (the other 15%, new-for-2026 shorter tier). Device cost ($40/enrolled/mo, unverified vendor cost) deducted as COGS against RPM gross revenue. |
| Abbott Piccolo Xpress NEW | POC chemistry analyzer — BMP, CMP, electrolytes, lipid (CLIA-waived discs, lithium heparin whole blood) | Day 1 | 0 | CoW | $17,178 one-time purchase (⚠ CHANGED — replaces the i-STAT Alinity, removed Oct 2026: CHEM8+ is no longer CLIA-waived) | Disc cost | Bills 80048QW BMP ($8.46: 100% of new patients + 10% of established/yr) and 80061QW lipid ($13.09). CMP (80053QW) is available on the device but not priced. COGS = 25% margin on rate. |
| CoaguChek XS Pro | PT/INR meter | Day 1 | 0 | CoW | $635 one-time purchase (⚠ CHANGED — moved from a Month 9 backup to Day 1 primary) | Strip cost | Bills 85610 ($4.29): 5% of established panel at 17x/yr. COGS = 25% margin on rate. |
| Afinion 2 | HbA1c analyzer (CLIA-waived, FDA CW210007) | Day 1 | 0 | CoW | $4,701 one-time purchase (was $3,000) | 25% margin on rate | Bills 83036 HbA1c only ($9.49, diabetic panel 4x/yr). ⚠ CHANGED: the US Afinion 2 does not run lipid or CRP and its ACR test is moderate complexity, so lipid moved to the Piccolo, ACR to the Clinitek, and CRP was removed. |
| Siemens Clinitek Status+ NEW | Urine ACR (semi-quantitative) + routine dipstick | Day 1 | 0 | CoW | $1,049 starter kit | Strips (operating cost) | Bills urine ACR as 82044QW ($6.23) + 82570QW ($5.18) = $11.41, diabetic panel 1x/yr — replaces the 82043 proxy ($7.00). Replaces the separate urinalysis reader. |
| Sysmex XW-100 | POC hematology analyzer — CBC | Day 1 | 0 | CoW | $6,000 one-time purchase (was $2,500) | 25% margin on rate | Bills 85025 ($7.59, 2026 CLFS), 100% of panel 1x/yr. Also reports hematocrit, so 85014 is not billed separately. |
| 12-Lead ECG Machine | Standard 12-lead for AWV cardiac screening and acute evaluation | Day 1 | 0 | None | $2,477 (Embra E-30; was $1,500) | Minimal (paper/gel) | Not itemized anywhere in the revenue engine — never had its own CPT code line, before or after the ancillary rebuild. Genuinely unmodeled, not folded into any bucket. |
| Rapid Tests (Antigen, QW) | Flu A/B, Strep A, RSV, COVID, combo, Mono — 6 CLIA-waived antigen tests | Day 1 | 0 | CoW (included) | $0 (consumables only) | 50% margin on rate | Live in Ancillary revenue: 87804/87880/87807/87811/87428/86308, all 2026 CLFS-confirmed rates — see Billing Code Sheet. Replaces the old, unitemized "Other" ancillary bucket (that bucket no longer exists). |
| Phase 2 · Month 6 (275+ Members · Clinical Confidence Established) | |||||||
| Butterfly iQ+ POCUS | Handheld ultrasound — DVT screening, cardiac, abdominal, pulmonary views | Month 6 | 275 | None | $2,699 (was $2,999) | Gel ~$2/scan + ~$420/yr membership | ⚠ NOT MODELED — the legacy ancillary bucket this used to be folded into (16% POCUS share) has been removed and NOT replaced with a real POCUS revenue line, pending real Butterfly IQ device costing and CPT code decisions (76705 abdominal, 93308 limited cardiac, 76604 pulmonary, 93970/93971 DVT duplex were researched but never wired in). This is a genuine revenue reduction versus the prior version, not a reclassification. |
FLAGGED_ASSUMPTIONS array in this page's script. Every item that is NOT a confirmed 2026 CMS/CLFS rate — every code-mix split, enrollment rate, panel-composition percentage, and cost placeholder — is listed here with its flag type and a plain-language explanation of where it came from and why it was kept.| Assumption | Flag | Explanation |
|---|
Equipment costs sourced from Spark Senior Health clinical model. CMS billing rates: 2026 MPFS (CF $33.40) × 0.85 NP factor, no HPSA bonus. Lab codes: 2026 CLFS. Validate all independently before investor distribution.
| Category | Useful Life | Per Clinic (Flagship) | Per Clinic (Expansion) | Y1 Total | Y2 Total | Y3 Total | Y1–Y3 Total |
|---|
| Item | Notes | Phase | Flagship | Expansion |
|---|
| Category | Per-Clinic Cost | Method | Useful Life | Annual Depr | Funded by Raise |
|---|
CapEx estimates based on Spark Senior Health clinical model for clinical equipment; published market rates for buildout, furniture, technology, and vehicles. Clinical equipment and furniture re-priced line by line in the Oct 2026 CapEx update (each line's status shown under its note); all lab devices are one-time purchases (no lease option). All figures are estimates — obtain 3 contractor bids for buildout and 2 dealer quotes for vehicles before finalizing. Depreciation: straight-line over each category's assumed useful life (5-yr for all lab devices — a judgment call, matching other Clinical Equipment; no explicit useful life was specified for these two new devices). Validate with CPA.
| Category | Year 1 · Series Seed | Year 2 · Series A | Year 3 · Series B / Self-Funded | Year 4 · Steady State | Year 5 · Steady State | 5-Year Total |
|---|
| Month | Period | Raise In | CapEx Out | Operating Cash | Total Cash Out | Cash Balance | Notes |
|---|
Operating cash = net profit from the monthly P&L engine plus depreciation added back (D&A is non-cash; CapEx is deducted separately in its own column) (no interest expense — the Series Seed raise is equity, not debt, whether $4M Lease or $5M Own/Mortgage). CapEx is front-loaded at each clinic's launch month for simplicity. Cash balance must remain positive at all times; if it goes negative, the raise is insufficient for that scenario.
The six Y1 executives run their functions hands-on (the Chief HR Officer joins in Y2 and the Chief Medical Officer in Y4). A role is added only when volume makes an executive the bottleneck, and specialist work is contracted until it is steady enough to bring in-house. The selected year is highlighted.
MSO functions by year, plus the PC's clinical-authority line at the bottom. Summary counts cover MSO functions only.
Each row is the year a position is first filled, gains seats, or is retitled. Clinic care-team rows show FTE added across all clinics.
| Role | Entity | At opening | Growth rule | Notes |
|---|---|---|---|---|
| Nurse Practitioner / Physician Assistant | PC | 1 full-time | Model ladder, 85% of visit capacity | Bills under own NPI; covered by a collaborating-physician protocol. |
| Lead NP (designation) | PC | — | Clinics with 2+ NP/PAs | Reduced panel plus on-site clinical leadership. |
| Licensed Practical Nurse (or MA) | PC | 1 | 1 per ~500 patients | LPN preferred for CCM/APCM clinical-staff defensibility. With care coordinators, LPNs handle RPM monitoring and alerts in every year. |
| Care Coordinator | PC | 1 | 1 per ~500 patients | CCM/APCM/BHI/RPM time, care plans, RPM reading follow-up, TCM outreach, AWV scheduling. |
| Patient Services Representative | TBD | 1 | 2 above 750 patients | Check-in, eligibility, desk collections. Phones centralize to Patient Access from Y3 (lean) or Y2 (full). |
| Community Transport Driver | TBD | 1 | 1 | One van per clinic. |
Every clinician is a PC employee who reports up the PC. The COO chain is their operational lead, shown dotted: it directs how the clinic runs, not who is hired or fired and not any medical decision.
| Role | Employer | Solid line: reports to | Dotted line: operational lead / setup | Who decides what |
|---|---|---|---|---|
| NP / PA | PC | Supervising physician (Lead NP at clinics with 2+ NP/PAs) → Physician Owner | Director of Clinic Ops / Regional Manager → COO | Hiring, firing, discipline, protocols, delegation, medical guidance: supervising physician. Schedules, workflow, supplies, onboarding logistics: COO chain. |
| LPN / MA | PC | Clinic NP / Lead NP → supervising physician | COO chain | Same split. MAs work under physician delegation, so they sit with the PC. LPNs and care coordinators monitor RPM readings and alerts. |
| Care Coordinator | PC | Clinic NP / Lead NP → supervising physician | COO chain; program workflows from the Care Management Program Manager (MSO) | Clinical supervision stays with the PC. The MSO administers CCM/APCM/RPM program mechanics. |
| Lead NP | PC | Chief NP Officer (from Y3) or supervising physician | COO chain | Handles day-to-day performance issues; escalates hire/fire decisions to the physician. |
| Behavioral Health care managers (hub, optional) | PC | Physician Owner | Care Management Program Manager (program administration) | Clinical review and escalation: PC. Platform and workflow administration: MSO. |
| Front desk (Patient Services Rep) | TBD | Director of Clinic Ops / Regional Manager (COO chain) | — | Non-clinical; direct operational reports. Employer entity is an open decision. |
| Community Transport Driver | TBD | CGO | COO chain: vehicle setup, dispatch, Samsara monitoring, compliance | Guardrail on the CGO line: rides not advertised, no marketing during rides. |
The PC is owned by a contracted Georgia-licensed Physician Owner who covers all clinics. Collaborating physicians are also contracted: one from Year 1, then one per 8 NP/PA heads under Georgia's combined APRN + PA limit (O.C.G.A. § 43-34-25). The owner is not counted as a collaborator. Contracted physicians are excluded from FTE totals; cost is pending the Permit Health bid.
Seats by year for every role in both builds (Y1·Y2·Y3·Y4·Y5). Where the lean build has no seat, the last column shows who covers the work instead.
Each executive runs a function directly in Y1. The first hire under each is the person who removes that executive as a bottleneck: Billing & Coding Lead (CFO), Health IT Implementation Specialist (CDIO), Community Outreach (CGO), then the Director of Clinic Operations in Y2 (the COO covers Medicare enrollment through a contracted consultant).
Specialist or uneven work (bookkeeping, marketing, IT help desk, coding audit, MIPS, security assessment, Medicare enrollment, and contingency recruiting) is contracted until volume is steady enough to justify a seat.
AI scribing and the RCM vendor do the mechanical work. The PC carries billing liability, care-management rules are strict, and a percentage-of-collections vendor has no incentive to chase small denials, so one in-house lead owns it from day one.
Clinical staff are PC employees. They report up the PC to the supervising physician, who alone decides hiring, firing, discipline, protocols, and medical guidance. The COO chain is their operational lead (dotted): scheduling, workflow, facilities, supplies. The Physician Owner holds clinical authority and is not the Medical Director. A Medical Director is hired in the MSO later (Y4) for policy guidance only, with no clinical authority.
People (HR), led by the Chief HR Officer, reports to the COO. Y1 uses a contracted HR consultant under the COO; the Chief HR Officer and an HR Generalist start in Y2.
Drivers report to the CGO. The COO chain sets up vehicles and dispatch and monitors compliance through Samsara. The CGO line carries a guardrail: rides are not advertised and drivers do not market during rides.
| Decision | Owner | Why it matters |
|---|---|---|
| Employer entity for front desk and drivers | CCO/CLO | Affects the MSA fee structure and Stark/AKS review of the related-party transportation arrangement. MAs sit with the PC (delegated clinical work). Drivers report to the CGO, so the transportation safe-harbor guardrail applies to that line. |
| Pull Controller and West Regional Manager into late Y2 | CEO / CFO / COO | Spreads the Y3 load of four openings and eight MSO hires. |
| MSO Chief Medical Officer scope (Y4) | CCO/CLO | Policy guidance only. Have counsel confirm the role description and reporting so MSO advice cannot read as direction of the PC's clinical decisions. The PC adopts all clinical policy. |
| Building ownership structure | CFO / CCO/CLO | The model assumes the company owns its clinic buildings (mortgage option). Decide which entity holds title and how the PC occupies the space; have counsel confirm rent terms (fair market value, set in advance) against Stark/AKS. |
| Site-level day-to-day lead | COO / Physician Owner | A Lead NP in a dual role (operational direction from the COO chain, clinical direction from the physician) or a Clinic Manager. At single-NP clinics the NP would carry both. |
| Physician hire/fire authority in the Permit Health contract | CCO/CLO | Supervising physicians hold hiring, firing, and discipline for up to 8 NPs each. The contract must give that authority in practice, with the Lead NP or Chief NP Officer handling day-to-day performance issues. |
| Permit Health physician arrangement | CCO/CLO | Confirm the bid structure against the May 2026 GCMB position statement on paid physician-matching services, the PC ownership requirements, and fair-market-value terms before signing. |
| CFO full-time conversion date | CEO / CFO | The CFO's executive tranche is contingent on full-time hire. |
| Behavioral Health hub and CoCM in Y3 | Physician Owner / COO | Optional in the lean build; requires a contracted psychiatric consultant. |
| Expansion-readiness roles | Board | Payer Contracting, Market Development, and AI & Automation only if expansion is funded. |
This organization design is independent of the financial model's staffing costs and salaries. To price it, the MSO staff line and clinic staffing engine would need to be rebuilt against these roles.